These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Exact name of Registrant as specified in its charter)
|
||
|
Maryland
|
38-3041398
|
|
|
(State of incorporation)
|
(IRS Employer
Identification No.)
|
|
|
200 International Circle, Suite 3500, Hunt Valley, MD 21030
|
||
|
(Address of principal executive offices)
|
||
|
(410) 427-1700
|
||
|
(Telephone number, including area code)
|
||
|
Page No.
|
||
|
PART I
|
Financial Information
|
|
|
Item 1.
|
Financial Statements:
|
|
|
September 30, 2010 (unaudited) and December 31, 2009
|
2
|
|
|
Three and nine months ended September 30, 2010 and 2009
|
3
|
|
|
Nine months ended September 30, 2010 (unaudited)
|
4
|
|
|
Nine months ended September 30, 2010 and 2009
|
5
|
|
|
September 30, 2010 (unaudited)
|
6
|
|
|
Item 2.
|
26 | |
|
|
|
|
|
Item 3.
|
41
|
|
|
Item 4.
|
41
|
|
|
PART II
|
Other Information
|
|
|
Item 1.
|
42
|
|
|
Item 1A.
|
42
|
|
|
Item 6.
|
45
|
|
| September 30, | December 31, | |||||||
| 2010 | 2009 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Real estate properties | ||||||||
|
Land and buildings
|
$ | 2,352,372 | $ | 1,669,843 | ||||
|
Less accumulated depreciation
|
(355,274 | ) | (296,441 | ) | ||||
|
Real estate properties – net
|
1,997,098 | 1,373,402 | ||||||
|
Mortgage notes receivable – net
|
90,252 | 100,223 | ||||||
| 2,087,350 | 1,473,625 | |||||||
|
Other investments – net
|
31,340 | 32,800 | ||||||
| 2,118,690 | 1,506,425 | |||||||
|
Assets held for sale – net
|
670 | 877 | ||||||
|
Total investments
|
2,119,360 | 1,507,302 | ||||||
|
Cash and cash equivalents
|
1,192 | 2,170 | ||||||
|
Restricted cash
|
21,151 | 9,486 | ||||||
|
Accounts receivable – net
|
90,780 | 81,558 | ||||||
|
Other assets
|
60,440 | 50,778 | ||||||
|
Operating assets for owned and operated properties
|
635 | 3,739 | ||||||
|
Total assets
|
$ | 2,293,558 | $ | 1,655,033 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Revolving line of credit
|
$ | 143,000 | $ | 94,100 | ||||
|
Secured borrowings
|
302,210 | 159,354 | ||||||
|
Unsecured borrowings – net
|
702,947 | 484,695 | ||||||
|
Accrued expenses and other liabilities
|
122,739 | 49,895 | ||||||
|
Operating liabilities for owned and operated properties
|
1,579 | 1,762 | ||||||
|
Total liabilities
|
1,272,475 | 789,806 | ||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock issued and outstanding – 4,340 shares Series D with an aggregate liquidation preference of $108,488
|
108,488 | 108,488 | ||||||
|
Common stock $.10 par value authorized – 200,000 shares issued and outstanding – 98,236 shares as of September 30, 2010 and 88,266 as of December 31, 2009
|
9,824 | 8,827 | ||||||
|
Common stock – additional paid-in-capital
|
1,358,564 | 1,157,931 | ||||||
|
Cumulative net earnings
|
575,855 | 522,388 | ||||||
|
Cumulative dividends paid
|
(1,031,648 | ) | (932,407 | ) | ||||
|
Total stockholders’ equity
|
1,021,083 | 865,227 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 2,293,558 | $ | 1,655,033 | ||||
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenue
|
||||||||||||||||
|
Rental income
|
$ | 66,299 | $ | 41,226 | $ | 165,028 | $ | 123,626 | ||||||||
|
Mortgage interest income
|
2,576 | 2,915 | 7,709 | 8,686 | ||||||||||||
|
Other investment income – net
|
746 | 694 | 3,282 | 1,844 | ||||||||||||
|
Miscellaneous
|
103 | 160 | 3,852 | 364 | ||||||||||||
|
Nursing home revenues of owned and operated assets
|
- | 4,758 | 7,336 | 13,545 | ||||||||||||
|
Total operating revenues
|
69,724 | 49,753 | 187,207 | 148,065 | ||||||||||||
|
Expenses
|
||||||||||||||||
|
Depreciation and amortization
|
27,742 | 11,093 | 58,880 | 33,014 | ||||||||||||
|
General and administrative
|
4,376 | 2,675 | 11,758 | 8,920 | ||||||||||||
|
Acquisition costs
|
78 | - | 1,490 | - | ||||||||||||
|
Impairment loss on real estate properties
|
- | 89 | 155 | 159 | ||||||||||||
|
Nursing home expenses of owned and operated assets
|
480 | 4,899 | 7,849 | 15,750 | ||||||||||||
|
Total operating expenses
|
32,676 | 18,756 | 80,132 | 57,843 | ||||||||||||
|
Income before other income and expense
|
37,048 | 30,997 | 107,075 | 90,222 | ||||||||||||
|
Other income (expense):
|
||||||||||||||||
|
Interest income
|
11 | 2 | 88 | 19 | ||||||||||||
|
Interest expense
|
(19,070 | ) | (9,171 | ) | (47,350 | ) | (26,656 | ) | ||||||||
|
Interest – amortization of deferred financing and refinancing costs
|
(978 | ) | (690 | ) | (6,342 | ) | (2,216 | ) | ||||||||
|
Litigation settlements
|
- | - | - | 4,527 | ||||||||||||
|
Total other expense
|
(20,037 | ) | (9,859 | ) | (53,604 | ) | (24,326 | ) | ||||||||
|
Income before loss on assets sold
|
17,011 | 21,138 | 53,471 | 65,896 | ||||||||||||
|
Loss on assets sold – net
|
(4 | ) | - | (4 | ) | (24 | ) | |||||||||
|
Net income
|
17,007 | 21,138 | 53,467 | 65,872 | ||||||||||||
|
Preferred stock dividends
|
(2,271 | ) | (2,271 | ) | (6,814 | ) | (6,814 | ) | ||||||||
|
Net income available to common
|
$ | 14,736 | $ | 18,867 | $ | 46,653 | $ | 59,058 | ||||||||
|
Income per common share available to common shareholders:
|
||||||||||||||||
|
Basic:
|
||||||||||||||||
|
Net income
|
$ | 0.15 | $ | 0.23 | $ | 0.50 | $ | 0.71 | ||||||||
|
Diluted:
|
||||||||||||||||
|
Net income
|
$ | 0.15 | $ | 0.22 | $ | 0.50 | $ | 0.71 | ||||||||
|
Dividends declared and paid per common share
|
$ | 0.36 | $ | 0.30 | $ | 1.00 | $ | 0.90 | ||||||||
|
Weighted-average shares outstanding, basic
|
95,698 | 83,740 | 92,523 | 82,903 | ||||||||||||
|
Weighted-average shares outstanding, diluted
|
95,987 | 83,858 | 92,700 | 83,004 | ||||||||||||
|
Components of other comprehensive income:
|
||||||||||||||||
|
Net income
|
$ | 17,007 | $ | 21,138 | $ | 53,467 | $ | 65,872 | ||||||||
|
Total comprehensive income
|
$ | 17,007 | $ | 21,138 | $ | 53,467 | $ | 65,872 | ||||||||
|
Preferred
Stock
|
Common Stock Par Value
|
Additional
Paid-in Capital
|
Cumulative
Net Earnings
|
Cumulative
Dividends
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2009 (88,266 common shares)
|
$ | 108,488 | $ | 8,827 | $ | 1,157,931 | $ | 522,388 | $ | (932,407 | ) | $ | 865,227 | |||||||||||
|
Issuance of common stock:
|
||||||||||||||||||||||||
|
Grant of restricted stock (13 shares at $20.00 per share)
|
— | 1 | (1 | ) | — | — | — | |||||||||||||||||
|
Amortization of restricted stock
|
— | — | 1,732 | — | — | 1,732 | ||||||||||||||||||
|
Dividend reinvestment plan (2,154 shares at $20.00 per share)
|
— | 216 | 42,853 | — | — | 43,069 | ||||||||||||||||||
|
Exercised options (15 shares at an average exercise price of $6.12 per share)
|
— | 1 | 88 | — | — | 89 | ||||||||||||||||||
|
Grant of stock as payment of directors fees (6 shares at an average of $19.60 per share)
|
— | 1 | 112 | — | — | 113 | ||||||||||||||||||
|
Equity Shelf Program (6,789 shares at $20.72 per share, net of issuance costs)
|
— | 679 | 136,255 | — | — | 136,934 | ||||||||||||||||||
|
Issuance of common stock for acquisition (995 shares at $19.80 per share)
|
— | 99 | 19,594 | — | — | 19,693 | ||||||||||||||||||
|
Net income
|
— | — | — | 53,467 | — | 53,467 | ||||||||||||||||||
|
Common dividends ($1.00 per share).
|
— | — | — | — | (92,427 | ) | (92,427 | ) | ||||||||||||||||
|
Preferred dividends (Series D of $1.57 per share)
|
— | — | — | — | (6,814 | ) | (6,814 | ) | ||||||||||||||||
|
Balance at September 30, 2010 (98,236 common shares)
|
$ | 108,488 | $ | 9,824 | $ | 1,358,564 | $ | 575,855 | $ | (1,031,648 | ) | $ | 1,021,083 | |||||||||||
|
Nine Months Ended
September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash flows from operating activities
|
||||||||
|
Net income
|
$ | 53,467 | $ | 65,872 | ||||
|
Adjustment to reconcile net income to cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
58,880 | 33,014 | ||||||
|
Impairment loss on real estate properties
|
155 | 159 | ||||||
|
Amortization of deferred financing and refinancing costs
|
6,342 | 2,216 | ||||||
|
Restricted stock amortization expense
|
1,756 | 1,439 | ||||||
|
Loss (gain) on assets sold – net
|
4 | 24 | ||||||
|
Amortization of other non-cash interest charges
|
27 | — | ||||||
|
Amortization of in-place leases
|
(1,852 | ) | — | |||||
|
Other
|
(113 | ) | (129 | ) | ||||
|
Gain on sale of securities
|
(789 | ) | — | |||||
|
Change in operating assets and liabilities – net of amounts assumed/acquired:
|
||||||||
|
Accounts receivable, net
|
(2,033 | ) | 219 | |||||
|
Straight-line rent
|
(6,928 | ) | (6,987 | ) | ||||
|
Lease inducement
|
(261 | ) | 532 | |||||
|
Other operating assets and liabilities
|
(1,132 | ) | 10,117 | |||||
|
Operating assets and liabilities for owned and operated properties
|
2,921 | 7,959 | ||||||
|
Net cash provided by operating activities
|
110,444 | 114,435 | ||||||
|
Cash flows from investing activities
|
||||||||
|
Acquisition of real estate – net of liabilities assumed and escrows acquired
|
(343,180 | ) | — | |||||
|
Placement of mortgage loans
|
(2,372 | ) | — | |||||
|
Proceeds from sale of real estate investments
|
81 | 85 | ||||||
|
Capital improvements and funding of other investments
|
(25,658 | ) | (14,640 | ) | ||||
|
Proceeds from other investments
|
18,720 | 39,515 | ||||||
|
Investments in other investments
|
(16,436 | ) | (39,075 | ) | ||||
|
Collection of mortgage principal – net
|
60 | 403 | ||||||
|
Net cash used in investing activities
|
(368,785 | ) | (13,712 | ) | ||||
|
Cash flows from financing activities
|
||||||||
|
Proceeds from credit facility borrowings
|
314,000 | 138,500 | ||||||
|
Payments on credit facility borrowings
|
(265,100 | ) | (193,000 | ) | ||||
|
Receipts of other long-term borrowings
|
196,556 | — | ||||||
|
Payments of other long-term borrowings
|
(59,882 | ) | — | |||||
|
Payment of financing related costs
|
(9,231 | ) | (4,574 | ) | ||||
|
Receipts from dividend reinvestment plan
|
43,069 | 17,073 | ||||||
|
Net proceeds from issuance of common stock
|
136,934 | 23,095 | ||||||
|
Payments from exercised options – net
|
89 | — | ||||||
|
Dividends paid
|
(99,072 | ) | (81,380 | ) | ||||
|
Net cash provided by (used in) financing activities
|
257,363 | (100,286 | ) | |||||
|
(Decrease) increase in cash and cash equivalents
|
(978 | ) | 437 | |||||
|
Cash and cash equivalents at beginning of period
|
2,170 | 209 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 1,192 | $ | 646 | ||||
|
Interest paid during the period, net of amounts capitalized
|
$ | 41,764 | $ | 24,508 | ||||
|
Non-cash investing activities
|
||||||||
|
Assumed debt obligations
|
$ | 202,015 | $ | — | ||||
|
Non-cash settlement of mortgage obligations
|
(12,395 | ) | — | |||||
|
Non-cash acquisition of real estate properties
|
12,395 | — | ||||||
|
Stock consideration issued for acquisition
|
19,693 | — | ||||||
|
Net non-cash investing activities
|
$ | 221,708 | $ | — | ||||
|
September 30,
2010
|
December 31, 2009
|
|||||||
|
(in thousands)
|
||||||||
|
Contractual receivables
|
$ | 6,107 | $ | 2,818 | ||||
|
Straight-line receivables
|
58,185 | 52,395 | ||||||
|
Lease inducements
|
29,281 | 29,020 | ||||||
|
Allowance
|
(2,793 | ) | (2,675 | ) | ||||
|
Accounts receivable
–
net
|
$ | 90,780 | $ | 81,558 | ||||
|
Less than 1 year
|
1-3 years
|
3-5 years
|
Thereafter
|
|
1.6
|
2.3
|
1.9
|
(0.6)
|
|
·
|
$65 million in cash,
|
|
·
|
$202 million face value of assumed debt, which includes $20 million of 9.0% unsecured debt maturing in December 2021, $53
million of HUD debt at a 6.61% weighted average annual interest rate maturing between January 2036 and May 2040, and $129 million of new HUD Debt at a 4.85% annual interest rate maturing between January 2040 and January 2045, and
|
|
·
|
995 thousand shares of our common stock valued at approximately $19 million on June 29, 2010.
|
|
Less than 1 year
|
1-3 years
|
3-5 years
|
Thereafter
|
|
3.6
|
6.2
|
4.9
|
2.7
|
|
Less than 1 year
|
1-3 years
|
3-5 years
|
Thereafter
|
|
0.6
|
2.6
|
3.3
|
5.2
|
|
Pro Forma
|
||||||||||||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(in thousands, except per share amount, unaudited)
|
||||||||||||||||
|
Revenues
|
$ | 69,724 | $ | 74,575 | $ | 218,420 | $ | 222,532 | ||||||||
|
Net income available to common
|
$ | 14,736 | $ | 23,652 | $ | 52,746 | $ | 73,412 | ||||||||
|
Earnings per share – diluted:
|
||||||||||||||||
|
Net income available to common – as reported
|
$ | 0.15 | $ | 0.22 | $ | 0.50 | $ | 0.71 | ||||||||
|
Net income available to common – pro forma
|
$ | 0.15 | $ | 0.27 | $ | 0.56 | $ | 0.85 | ||||||||
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Nursing home revenues
|
$ | — | $ | 4,758 | $ | 7,336 | $ | 13,545 | ||||||||
|
Nursing home expenses
|
480 | 4,899 | 7,849 | 15,750 | ||||||||||||
|
Loss from nursing home operations
|
$ | (480 | ) | $ | (141 | ) | $ | (513 | ) | $ | (2,205 | ) | ||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Restricted stock expense
|
$ | 450 | $ | 480 | $ | 1,756 | $ | 1,439 | ||||||||
|
Shares/ Units
|
Grant Date Fair Value Per Unit/ Share
|
Total Compensation Cost
|
Weighted Average Period of Expense Recognition (in months)
|
Unrecognized Compensation Cost
|
||||||||||||||||
|
(in thousands, except share and per share amounts)
|
||||||||||||||||||||
|
Restricted stock
|
286,908 | $ | 17.06 | $ | 4,895 | 44 | $ | 334 | ||||||||||||
|
2008 Annual performance restricted stock units
|
41,332 | 8.78 | 363 | 20 | - | |||||||||||||||
|
2009 Annual performance restricted stock units, including modification
|
41,332 | 19.10 | 789 | 32 | - | |||||||||||||||
|
2010 Annual performance restricted stock units
|
41,332 | 8.14 | 255 | 44 | 17 | |||||||||||||||
|
3 year cliff vest performance restricted stock units
|
123,996 | 6.17 | 765 | 44 | 52 | |||||||||||||||
|
Total
|
534,900 | $ | 7,067 | $ | 403 | |||||||||||||||
|
Current
|
September 30,
|
December 31,
|
||||||||||||||
|
Maturity
|
Rate
|
2010
|
2009
|
|||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Secured borrowings:
|
||||||||||||||||
|
Revolving lines of credit
|
2014
|
4.26 | % | $ | 143,000 | $ | 94,100 | |||||||||
|
GECC Term loan
|
2014
|
6.50 | % | 100,000 | 100,000 | |||||||||||
|
CapitalSource mortgage
|
2011
|
6.80 | % | — | 59,354 | |||||||||||
|
HUD Berkadia mortgages
(1)
|
2036 - 2040 | 6.61 | % | 53,088 | — | |||||||||||
|
HUD Capital Funding mortgage
|
2040 - 2045 | 4.85 | % | 128,399 | — | |||||||||||
| 281,487 | 159,354 | |||||||||||||||
|
Fair value adjustment at assumption date
(2)
|
20,723 | — | ||||||||||||||
|
Total secured borrowings
|
302,210 | 159,354 | ||||||||||||||
|
Unsecured borrowings:
|
||||||||||||||||
|
2014 Notes
|
2014 | 7.0 | % | $ | 310,000 | $ | 310,000 | |||||||||
|
2016 Notes
|
2016 | 7.0 | % | 175,000 | 175,000 | |||||||||||
|
2020 Notes
|
2020 | 7.5 | % | 200,000 | — | |||||||||||
|
HUD subordinated debt
|
2021 | 9.0 | % | 20,000 | — | |||||||||||
| 705,000 | 485,000 | |||||||||||||||
|
Discount
|
(3,504 | ) | (305 | ) | ||||||||||||
|
Fair value adjustment at assumption date
(2)
|
1,451 | — | ||||||||||||||
|
Total unsecured borrowings
|
702,947 | 484,695 | ||||||||||||||
|
Totals - net
|
$ | 1,148,157 | $ | 738,149 | ||||||||||||
|
(1)
|
Reflects the weighted average interest rate on the Berkadia mortgages.
|
|
(2)
|
Adjustment to reflect assumption of debt to fair market value. The debt was assumed as part of the HUD Portfolio closing on June 29, 2010.
|
|
September 30,
2010
|
December 31,
2009
|
|||||||||||||||
|
Carrying
Amount
|
Fair
Value
|
Carrying
Amount
|
Fair
Value
|
|||||||||||||
|
Assets:
|
(in thousands)
|
|||||||||||||||
|
Cash and cash equivalents
|
$ | 1,192 | $ | 1,192 | $ | 2,170 | $ | 2,170 | ||||||||
|
Restricted cash
|
21,151 | 21,151 | 9,486 | 9,486 | ||||||||||||
|
Mortgage notes receivable – net
|
90,252 | 88,413 | 100,223 | 98,251 | ||||||||||||
|
Other investments – net
|
31,340 | 27,772 | 32,800 | 29,725 | ||||||||||||
|
Totals
|
$ | 143,935 | $ | 138,528 | $ | 144,679 | $ | 139,632 | ||||||||
|
Liabilities:
|
||||||||||||||||
|
Revolving lines of credit
|
$ | 143,000 | $ | 143,000 | $ | 94,100 | $ | 94,100 | ||||||||
|
6.50% GECC Term loan
|
100,000 | 103,862 | 100,000 | 100,000 | ||||||||||||
|
6.80% CapitalSource Mortgage Note
|
— | — | 59,354 | 59,354 | ||||||||||||
|
7.00% Notes due 2014 – net
|
310,554 | 350,100 | 310,673 | 315,196 | ||||||||||||
|
7.00% Notes due 2016 – net
|
174,171 | 185,264 | 174,022 | 175,710 | ||||||||||||
|
7.50 % Notes due 2020 – net
|
196,771 | 209,557 | — | — | ||||||||||||
|
HUD debt
(1)
|
202,210 | 212,296 | — | — | ||||||||||||
|
Subordinated debt
(1)
|
21,451 | 23,314 | — | — | ||||||||||||
|
Totals
|
$ | 1,148,157 | $ | 1,227,393 | $ | 738,149 | $ | 744,360 | ||||||||
|
(1)
|
The carrying value of debt includes a fair value adjustment to reflect value of the debt assumed as part of the June 29, 2010 acquisition of the HUD portfolio.
|
|
·
|
Cash and cash equivalents and restricted cash: The carrying amount of cash and cash equivalents and restricted cash reported in the balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days).
|
|
·
|
Mortgage notes receivable: The fair values of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings.
|
|
·
|
Other investments: Other investments are primarily comprised of: (i) notes receivable; and (ii) an investment in redeemable non-convertible preferred security of an unconsolidated business accounted for using the cost method of accounting. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings. The fair value of the investment in the unconsolidated business is estimated using discounted cash flow and volatility assumptions or, if available, quoted market value and considers the terms of the underlying arrangement.
|
|
·
|
Revolving lines of credit: The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates.
|
|
·
|
Senior notes and other long-term borrowings: The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party.
|
|
Three Months Ended September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(in thousands, except per share amounts)
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Income from continuing operations
|
$ | 17,007 | $ | 21,138 | $ | 53,467 | $ | 65,872 | ||||||||
|
Preferred stock dividends
|
(2,271 | ) | (2,271 | ) | (6,814 | ) | (6,814 | ) | ||||||||
|
Numerator for net income available to common per share - basic and diluted
|
$ | 14,736 | $ | 18,867 | $ | 46,653 | $ | 59,058 | ||||||||
|
Denominator:
|
||||||||||||||||
|
Denominator for basic earnings per share
|
95,698 | 83,740 | 92,523 | 82,903 | ||||||||||||
|
Effect of dilutive securities:
|
||||||||||||||||
|
Restricted stock
|
281 | 107 | 168 | 89 | ||||||||||||
|
Stock option incremental shares
|
— | 11 | 3 | 11 | ||||||||||||
|
Deferred stock
|
8 | — | 6 | 1 | ||||||||||||
|
Denominator for diluted earnings per share
|
95,987 | 83,858 | 92,700 | 83,004 | ||||||||||||
|
Earnings per share – basic:
|
||||||||||||||||
|
Net income – basic
|
$ | 0.15 | $ | 0.23 | $ | 0.50 | $ | 0.71 | ||||||||
|
Earnings per share – diluted:
|
||||||||||||||||
|
Net income – diluted
|
$ | 0.15 | $ | 0.22 | $ | 0.50 | $ | 0.71 | ||||||||
|
September 30, 2010
|
||||||||||||||||
|
Issuer & Subsidiary Guarantors
|
Non – Guarantor Subsidiaries
|
Elimination Company
|
Consolidated
|
|||||||||||||
|
Land and buildings
|
$ | 2,039,975 | $ | 312,397 | $ | — | $ | 2,352,372 | ||||||||
|
Less accumulated depreciation
|
(351,230 | ) | (4,044 | ) | — | (355,274 | ) | |||||||||
|
Real estate properties – net
|
1,688,745 | 308,353 | — | 1,997,098 | ||||||||||||
|
Mortgage notes receivable – net
|
90,252 | — | — | 90,252 | ||||||||||||
| 1,778,997 | 308,353 | — | 2,087,350 | |||||||||||||
|
Other investments – net
|
31,340 | — | — | 31,340 | ||||||||||||
| 1,810,337 | 308,353 | — | 2,118,690 | |||||||||||||
|
Assets held for sale – net
|
670 | — | — | 670 | ||||||||||||
|
Total investments
|
1,811,007 | 308,353 | — | 2,119,360 | ||||||||||||
|
Cash and cash equivalents
|
1,192 | — | — | 1,192 | ||||||||||||
|
Restricted cash
|
8,982 | 12,169 | — | 21,151 | ||||||||||||
|
Accounts receivable – net
|
90,233 | 547 | — | 90,780 | ||||||||||||
|
Investment in affiliates
|
81,815 | — | (81,815 | ) | — | |||||||||||
|
Other assets
|
38,044 | 22,396 | — | 60,440 | ||||||||||||
|
Operating assets for owned and operated properties
|
635 | — | — | 635 | ||||||||||||
|
Total assets
|
$ | 2,031,908 | $ | 343,465 | (81,815 | ) | $ | 2,293,558 | ||||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||||||||||
|
Revolving line of credit
|
$ | 143,000 | $ | — | $ | — | $ | 143,000 | ||||||||
|
Secured borrowings
|
100,000 | 202,210 | — | 302,210 | ||||||||||||
|
Unsecured borrowings – net
|
681,496 | 21,451 | — | 702,947 | ||||||||||||
|
Accrued expenses and other liabilities
|
84,750 | 37,989 | — | 122,739 | ||||||||||||
|
Intercompany payable
|
— | 80,609 | (80,609 | ) | — | |||||||||||
|
Operating liabilities for owned and operated properties
|
1,579 | — | — | 1,579 | ||||||||||||
|
Total liabilities
|
1,010,825 | 342,259 | (80,609 | ) | 1,272,475 | |||||||||||
|
Stockholders’ equity:
|
||||||||||||||||
|
Preferred stock issued and outstanding – 4,340 shares Series D with an aggregate liquidation preference of $108,488
|
108,488 | — | — | 108,488 | ||||||||||||
|
Common stock $.10 par value authorized – 200,000 shares issued and outstanding – 98,236 shares as of September 30, 2010 and 88,266 as of December 31, 2009
|
9,824 | — | — | 9,824 | ||||||||||||
|
Common stock – additional paid-in-capital
|
1,358,564 | — | — | 1,358,564 | ||||||||||||
|
Cumulative net earnings
|
575,855 | 1,206 | (1,206) | 575,855 | ||||||||||||
|
Cumulative dividends paid
|
(1,031,648 | ) | — | — | (1,031,648 | ) | ||||||||||
|
Total stockholders’ equity
|
1,021,083 | 1,206 | (1,206) | 1,021,083 | ||||||||||||
|
Total liabilities and stockholders’ equity
|
$ | 2,031,908 | $ | 343,465 | $ | (81,815 | ) | $ | 2,293,558 | |||||||
|
Three Months Ended September 30, 2010
|
Nine Months Ended September 30, 2010
|
|||||||||||||||||||||||||||||||
|
Issuer & Subsidiary Guarantors
|
Non – Guarantor Subsidiaries
|
Elimination | Consolidated |
Issuer & Subsidiary Guarantors
|
Non – Guarantor Subsidiaries
|
Elimination | Consolidated | |||||||||||||||||||||||||
|
Revenue
|
||||||||||||||||||||||||||||||||
|
Rental income
|
$ | 57,992 | $ | 8,307 | $ | - | $ | 66,299 | $ | 156,569 | $ | 8,459 | $ | - | $ | 165,028 | ||||||||||||||||
|
Mortgage interest income
|
2,576 | - | - | 2,576 | 7,709 | - | - | 7,709 | ||||||||||||||||||||||||
|
Other investment income – net
|
746 | - | - | 746 | 3,282 | - | - | 3,282 | ||||||||||||||||||||||||
|
Miscellaneous
|
103 | - | - | 103 | 3,852 | - | - | 3,852 | ||||||||||||||||||||||||
|
Nursing home revenues of owned and operated assets
|
- | - | - | - | 7,336 | - | - | 7,336 | ||||||||||||||||||||||||
|
Total operating revenues
|
61,417 | 8,307 | - | 69,724 | 178,748 | 8,459 | - | 187,207 | ||||||||||||||||||||||||
|
Expenses
|
||||||||||||||||||||||||||||||||
|
Depreciation and amortization
|
23,772 | 3,970 | - | 27,742 | 54,836 | 4,044 | - | 58,880 | ||||||||||||||||||||||||
|
General and administrative
|
4,146 | 230 | - | 4,376 | 11,525 | 233 | - | 11,758 | ||||||||||||||||||||||||
|
Acquisition costs
|
78 | - | - | 78 | 1,490 | - | - | 1,490 | ||||||||||||||||||||||||
|
Impairment loss on real estate properties
|
- | - | - | - | 155 | - | - | 155 | ||||||||||||||||||||||||
|
Nursing home expenses of owned and operated assets
|
480 | - | - | 480 | 7,849 | - | - | 7,849 | ||||||||||||||||||||||||
|
Total operating expenses
|
28,476 | 4,200 | - | 32,676 | 75,855 | 4,277 | - | 80,132 | ||||||||||||||||||||||||
|
Income before other income and expense
|
32,941 | 4,107 | - | 37,048 | 102,893 | 4,182 | - | 107,075 | ||||||||||||||||||||||||
|
Other income (expense):
|
||||||||||||||||||||||||||||||||
|
Interest income
|
8 | 3 | - | 11 | 84 | 4 | - | 88 | ||||||||||||||||||||||||
|
Interest expense
|
(16,154 | ) | (2,916 | ) | - | (19,070 | ) | (44,370 | ) | (2,980 | ) | - | (47,350 | ) | ||||||||||||||||||
|
Interest – amortization of deferred financing and refinancing costs
|
(978 | ) | - | - | (978 | ) | (6,342 | ) | - | - | (6,342 | ) | ||||||||||||||||||||
|
Equity in earnings
|
1,194 | - | (1,194 | ) | - | 1,206 | - | (1,206 | ) | - | ||||||||||||||||||||||
|
Total other expense
|
(15,930 | ) | (2,913 | ) | (1,194 | ) | (20,037 | ) | (49,422 | ) | (2,976 | ) | (1,206 | ) | (53,604 | ) | ||||||||||||||||
|
Income before gain (loss) on assets sold
|
17,011 | 1,194 | (1,194 | ) | 17,011 | 53,471 | 1,206 | (1,206 | ) | 53,471 | ||||||||||||||||||||||
|
Loss on assets sold – net
|
(4 | ) | - | - | (4 | ) | (4 | ) | - | - | (4 | ) | ||||||||||||||||||||
|
Net income
|
17,007 | 1,194 | ) | (1,194 | ) | 17,007 | 53,467 | 1,206 | (1,206 | ) | 53,467 | |||||||||||||||||||||
|
Preferred stock dividends
|
(2,271 | ) | - | - | (2,271 | ) | (6,814 | ) | - | - | (6,814 | ) | ||||||||||||||||||||
|
Net income available to common
|
$ | 14,736 | $ | 1,194 | $ | (1,194 | ) | $ | 14,736 | $ | 46,653 | $ | 1,206 | $ | (1,206 | ) | $ | 46,653 | ||||||||||||||
|
(i)
|
those items discussed under “Risk Factors” in Item 1A to our annual report on Form 10-K for the year ended December 31, 2009 and in Part II, Item 1A of this report;
|
|
(ii)
|
uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels;
|
|
(iii)
|
the ability of any operators in bankruptcy to reject unexpired lease obligations, modify the terms of our mortgages and impede our ability to collect unpaid rent or interest during the process of a bankruptcy proceeding and retain security deposits for the debtors’ obligations;
|
|
(iv)
|
our ability to sell closed or foreclosed assets on a timely basis and on terms that allow us to realize the carrying value of these assets;
|
|
(v)
|
our ability to negotiate appropriate modifications to the terms of our credit facilities;
|
|
(vi)
|
our ability to manage, re-lease or sell any owned and operated facilities;
|
|
(vii)
|
the availability and cost of capital;
|
|
(viii)
|
changes in our credit ratings and the ratings of our debt and preferred securities;
|
|
(ix)
|
competition in the financing of healthcare facilities;
|
|
(x)
|
regulatory and other changes in the healthcare sector;
|
|
(xi)
|
the effect of economic and market conditions generally and, particularly, in the healthcare industry;
|
|
(xii)
|
changes in the financial position of our operators;
|
|
(xiii)
|
changes in interest rates;
|
|
(xiv)
|
the amount and yield of any additional investments;
|
|
(xv)
|
changes in tax laws and regulations affecting real estate investment trusts; and
|
|
(xvi)
|
our ability to maintain our status as a real estate investment trust.
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Net income available to common stockholders
|
$ | 14,736 | $ | 18,867 | $ | 46,653 | $ | 59,058 | ||||||||
|
Add back loss from real estate dispositions
|
4 | — | 4 | 24 | ||||||||||||
|
Sub-total
|
14,740 | 18,867 | 46,657 | 59,082 | ||||||||||||
|
Elimination of non-cash items included in net income:
|
||||||||||||||||
|
Depreciation and amortization
|
27,742 | 11,093 | 58,880 | 33,014 | ||||||||||||
|
Funds from operations available to common stockholders
|
$ | 42,482 | $ | 29,960 | $ | 105,537 | $ | 92,096 | ||||||||
|
|
Portfolio and Recent Developments
|
|
Less than 1 year
|
1-3 years
|
3-5 years
|
Thereafter
|
|
1.6
|
2.3
|
1.9
|
(0.6)
|
|
·
|
$65 million in cash,
|
|
·
|
$202 million face value of assumed debt, which includes $20 million of 9.0% unsecured debt maturing in December 2021, $53
million of HUD debt at a 6.61% weighted average annual interest rate maturing between January 2036 and May 2040, and $129 million of new HUD Debt at a 4.85% annual interest rate between January 2040 and January 2045, and
|
|
·
|
995 thousand shares of our common stock valued at approximately $19 million on June 29, 2010.
|
|
Less than 1 year
|
1-3 years
|
3-5 years
|
Thereafter
|
|
3.6
|
6.2
|
4.9
|
2.7
|
|
Less than 1 year
|
1-3 years
|
3-5 years
|
Thereafter
|
|
0.6
|
2.6
|
3.3
|
5.2
|
|
Payments due by period
|
||||||||||||||||||||
|
Total
|
Less than
1 year
|
1-3 years
|
3-5 years
|
More than
5 years
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||
|
Debt
(1)
|
$ | 1,129,487 | $ | - | $ | - | $ | 553,000 | $ | 576,487 | ||||||||||
|
Operating lease obligations
(2)
|
2,765 | 293 | 611 | 645 | 1,216 | |||||||||||||||
|
Total
|
$ | 1,132,252 | $ | 293 | $ | 611 | $ | 553,645 | $ | 577,703 | ||||||||||
|
(1)
|
The $1.1 billion includes $310 million aggregate principal amount of 7% Senior Notes due April 2014, $100 million aggregate principal amount of a 6.5% Term Loan due December 2014, $175 million aggregate principal amount of 7% Senior Notes due January 2016, $200 million of 7.5% senior notes due February 2020, $143 million in borrowings under the $320 million revolving senior secured credit facility (the “2010 Credit Facility”) due in April 2014,
$
20 million of 9.0% subordinated debt maturing in December 2021, $53
million of HUD debt at a 6.61% weighted average annual interest rate maturing between January 2036 and May 2040, and $128 million of HUD Debt at a 4.85% annual interest rate and maturing between January 2040 and January 2045.
|
|
(2)
|
Relates primarily to the lease at the corporate headquarters.
|
|
·
|
Medicare and Medicaid. A significant portion of our SNF and nursing home operators’ revenue is derived from governmentally-funded reimbursement programs, primarily Medicare and Medicaid. Failure to maintain certification in these programs would result in a loss of funding from such programs. See the risk factor entitled “Our operators depend on reimbursement from governmental and other third party payors and reimbursement rates from such payors may be reduced” for further discussion.
|
|
·
|
Licensing and Certification. Our operators and facilities are subject to regulatory and licensing requirements of federal, state and local authorities and are periodically surveyed by these authorities. Failure to obtain licensure or loss or suspension of licensure would prevent a facility from operating and result in ineligibility for reimbursement until the necessary licenses are obtained or reinstated. In such event, our revenues from these facilities could be reduced or eliminated for an extended period of time or permanently. In addition, licensing and Medicare and Medicaid laws require operators of nursing homes and assisted living facilities to comply with extensive standards governing operations. Federal and state agencies administering those laws regularly inspect such facilities and investigate complaints. Our operators and their managers receive notices of observed violations and deficiencies from time to time, and sanctions have been imposed from time to time on facilities operated by them. If our operators are unable to cure deficiencies, which have been identified or which are identified in the future, sanctions, including possible loss of license and/or right to receive reimbursement, may be imposed. If imposed, such sanctions may adversely affect our operators’ revenues, potentially jeopardizing their ability to meet their obligations to us.
|
|
·
|
Fraud and Abuse Laws and Regulations. There are various extremely complex civil and criminal federal and state laws governing a wide array of referrals, relationships and arrangements and prohibiting fraud by healthcare providers. Many of these laws raise issues that have not been clearly interpreted. Governments are devoting increasing attention and resources to anti-fraud initiatives against healthcare providers. The federal anti-kickback statute is a criminal statute that prohibits the knowing and willful offer, payment, solicitation or receipt of any remuneration in return for, to induce, or to arrange for the referral of individuals for any item or service payable by a federal or state healthcare program. There is also a civil analogue. States also have enacted similar statutes covering Medicaid payments and some states have broader statutes. Some enforcement efforts have targeted relationships between SNFs and ancillary providers, relationships between SNFs and referral sources for SNFs and relationships between SNFs and facilities for which the SNFs serve as referral sources. The federal self-referral law, commonly known as the “Stark Law,” is a civil statute that prohibits certain referrals by physicians to entities providing “designated health services” if these physicians have financial relationships with the entities. Some of the services provided in SNFs are classified as designated health services. There are also criminal provisions that prohibit filing false claims or making false statements to receive payment or certification under Medicare and Medicaid, as well as failing to refund overpayments or improper payments. Violation of the anti-kickback statute or Stark Law may form the basis for a False Claims Act violation. In addition, the federal False Claims Act allows a private individual with knowledge of fraud to bring a claim on behalf of the federal government and earn a percentage of the federal government’s recovery. Because of these incentives, these so-called “whistleblower” suits have become more frequent. The violation of any of these laws or regulations by an operator may result in the imposition of fines or other penalties, including exclusion from Medicare, Medicaid, and all other federal and state healthcare programs. Such fines or penalties could jeopardize that operator’s ability to make lease or mortgage payments to us or to continue operating its facility.
|
|
·
|
Privacy Laws. Our operators are subject to federal, state and local laws and regulations designed to protect confidentiality and security of patient health information, including the privacy and security provisions in the federal Health Insurance Portability and Accountability Act of 1996 and the corresponding regulations promulgated, known as HIPAA. HIPAA was amended by the American Recovery and Reinvestment Act of 2009, known as the Stimulus Bill, to increase penalties for HIPAA violations. These changes include the imposition of stricter requirements on healthcare providers, requiring notifications in most cases if there is a breach of an individual’s protected health information (including public announcements if the breach affects a significant number of individuals) and the expansion of possibilities for enforcement. Our operators may have to expend significant funds to secure the health information they hold, including upgrading their computer systems. If our operators are found in violation of HIPAA, such operators may be required to pay large penalties. Compliance with public notification requirements in the event of a breach could cause reputational harm to their business. Obligations to pay large penalties or tarnishing of reputation could adversely affect the ability of our operators to pay their obligations to us.
|
|
·
|
Other Laws. Other federal, state and local laws and regulations that impact how our operators conduct their operations include: (i) laws protecting consumers against deceptive practices; (ii) laws generally affecting our operators’ management of property and equipment and how our operators generally conduct their operations, such as fire, health and safety laws; (iii) laws affecting assisted living facilities mandating quality of services and care, including food services; and (iv) resident rights (including abuse and neglect laws) and health standards set by the federal Occupational Safety and Health Administration. We cannot predict the effect that the additional costs of complying with these laws may have on the revenues of our operators, and thus their ability to meet their obligations to us.
|
|
·
|
Legislative and Regulatory Developments. Each year, legislative and regulatory proposals are introduced at the federal and state levels that would result in major changes in the healthcare system. We cannot accurately predict whether any proposals will be adopted, and if adopted, what effect (if any) these proposals would have on our operators, and as a result, our business.
|
|
·
|
Beginning with fiscal year 2012, payments to SNFs will be subject to a productivity adjustment factor, which may reduce the market basket (cost of living) update, and which may result in a decrease of payments from the prior year.
|
|
·
|
The Secretary of the Department of Health and Human Services, or the Secretary, is required to develop plans for implementation of a value-based purchasing program for SNFs, taking into account quality and efficiency, the reporting, collection and validation of quality data, methods for public disclosure of performance information, and the structure of value-based payment adjustments.
|
|
·
|
By January 1, 2013, the Secretary is required to implement a pilot program to test the effect of bundling payments for acute care (hospitals and physicians) with payments for post acute care (SNFs, home health agencies, inpatient rehabilitation facilities, and long term care hospitals). The Centers for Medicare and Medicaid Services, or CMS, which implements the Medicare Program, would make one payment to cover hospitalization and care for 30 days after discharge for certain diagnoses. If the patient is readmitted to the hospital within 30 days of discharge, CMS could decide to reduce payment. The providers would be responsible for allocating payments.
|
|
·
|
The Secretary is required to submit to Congress by January 1, 2012 a report on whether it is appropriate or not to apply health care acquired conditions payment policy to SNFs. Such a policy, if adopted, could reduce payments to SNFs if residents acquire certain conditions during their care.
|
|
·
|
For cost reports submitted for cost reporting periods beginning on or after March 2010, nursing facilities will be required to disclose wages and benefits for staff (itemized by role) that provide direct care to residents.
|
|
Exhibit No.
|
||
|
4.1
|
Indenture, dated as of October 4, 2010, by and among Omega, the guarantors named therein and U.S. Bank National Association, as trustee (Incorporated by reference as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed October 5, 2010).
|
|
|
4.2
|
Registration Rights Agreement, dated as of October 4, 2010, by and among Omega, the guarantors named therein, and Banc of America Securities LLC, for itself and on behalf of the Initial Purchasers (Incorporated by reference as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed October 5, 2010).
|
|
|
10.1
|
Purchase Agreement, dated as of September 29, 2010, by and among Omega, the guarantors named therein, and Banc of America Securities LLC, for itself and on behalf of the Initial Purchasers (Incorporated by reference as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed October 5, 2010).
|
|
|
10.2
|
Employment Agreement, dated October 22, 2010 between Omega Healthcare Investors, Inc. and C. Taylor Pickett.
|
|
|
10.3
|
Employment Agreement, dated October 22, 2010 between Omega Healthcare Investors, Inc. and Daniel J. Booth.
|
|
|
10.4
|
Employment Agreement, dated October 22, 2010 between Omega Healthcare Investors, Inc. and Robert O. Stephenson.
|
|
|
10.5
|
Employment Agreement, dated October 22, 2010 between Omega Healthcare Investors, Inc. and R. Lee Crabill.
|
|
|
10.6
|
Employment Agreement, dated October 22, 2010 between Omega Healthcare Investors, Inc. and Michael Ritz.
|
|
|
31.1
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive Officer.
|
|
|
32.2
|
Section 1350 Certification of the Chief Financial Officer.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|